Product Introduction:
Sulbactomax combines cefoperazone (a third-generation cephalosporin) with sulbactam (a beta-lactamase inhibitor). This broadens the antibiotic’s effectiveness by protecting it from bacterial resistance mechanisms, making it valuable for various serious infections.
Uses:
-
Treatment of intra-abdominal infections (e.g., peritonitis)
-
Management of respiratory tract infections (e.g., pneumonia, bronchitis)
-
Effective in urinary and pelvic inflammatory infections
-
Treatment of skin, soft tissue, and bone/joint infections
-
Used in sepsis and febrile neutropenia as per doctor’s orders
Benefits:
-
Broader spectrum and enhanced efficacy compared to single-agent cephalosporins
-
Suitable for empiric therapy in serious infections
-
Effective against resistant gram-negative bacteria producing beta-lactamase
-
Administered by IV/IM, ensures high and predictable blood concentrations
Composition:
-
Cefoperazone – 250 mg
-
Sulbactam – 125 mg
-
Reconstitution medium: sterile water for injection
Side Effects:
-
Common: pain or inflammation at the injection site, diarrhea, headache, rash
-
May cause mild gastrointestinal upset like nausea
-
Rare but serious: allergic reactions, Clostridioides difficile–associated diarrhea, blood clotting anomalies
Safety Advice:
-
Administer under medical supervision via slow IV or deep IM injection after diluting per protocol
-
Dose and duration based on infection severity and patient condition
-
Monitor kidney and liver function, coagulation profile, and CBC during prolonged therapy
-
Use with caution in patients with clotting disorders, hepatic dysfunction, or penicillin/cephalosporin allergy
-
Complete the recommended course even if symptoms improve early
-
Keep hydrated; follow infusion instructions carefully to avoid vein irritation
-
Not recommended for patients with known cephalosporin hypersensitivity
-
Store at 15–25 °C; after reconstitution, refrigerate and use within recommended time per accompanying leaflet
-
Keep out of reach of children
